IFNA1 and COVID-19: The dysregulated functionality of DCs in COVID-19 is associated with viral antagonism of the phosphorylation of signal transducer and activator of transcription 1 (STAT1), which is a key regulator of type I, II, and type III IFN signaling pathway [60].